{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["13"],"submitter":["Kjellstadli C"],"pubmed_abstract":["<h4>Objective</h4>To investigate differences in cardiovascular disease (CVD) morbidity and mortality after radical prostatectomy or definitive radiotherapy with or without androgen deprivation therapy (ADT).<h4>Materials and methods</h4>We used population-based data from the Cancer Registry of Norway, the Norwegian Patient Registry and the Norwegian Cause of Death Registry including 19 289 men ≤80 years diagnosed with non-metastatic prostate cancer during 2010-2019. Patients were treated with radical prostatectomy or definitive radiotherapy. We used competing risk models to compare morbidity from overall CVD, acute myocardial infarction (AMI), cerebral infarction, thromboembolism, and CVD-specific mortality for the overall cohort and stratified by prognostic risk groups.<h4>Results</h4>Aft"],"journal":["Frontiers in oncology"],"pagination":["1121872"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10102587"],"repository":["biostudies-literature"],"pubmed_title":["Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study."],"pmcid":["PMC10102587"],"pubmed_authors":["Kjellstadli C","Forster RB","Myklebust TA","Bonaa KH","Kvale R","Helle SI","Bjorge T"],"additional_accession":[]},"is_claimable":false,"name":"Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study.","description":"<h4>Objective</h4>To investigate differences in cardiovascular disease (CVD) morbidity and mortality after radical prostatectomy or definitive radiotherapy with or without androgen deprivation therapy (ADT).<h4>Materials and methods</h4>We used population-based data from the Cancer Registry of Norway, the Norwegian Patient Registry and the Norwegian Cause of Death Registry including 19 289 men ≤80 years diagnosed with non-metastatic prostate cancer during 2010-2019. Patients were treated with radical prostatectomy or definitive radiotherapy. We used competing risk models to compare morbidity from overall CVD, acute myocardial infarction (AMI), cerebral infarction, thromboembolism, and CVD-specific mortality for the overall cohort and stratified by prognostic risk groups.<h4>Results</h4>Aft","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-04-04T12:44:01.428Z","creation":"2025-04-04T12:44:01.428Z"},"accession":"S-EPMC10102587","cross_references":{"pubmed":["37064117"],"doi":["10.3389/fonc.2023.1121872"]}}